Announces Regular Quarterly Cash Dividend of $0.17 Per Share Reaffirms Full Year 2025 Revenue and Earnings Guidance WINTER SPRINGS, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today its financial results for the three months ended March 31, 2025. The Company is a leader in developing innovative magnetic resonance imaging ("MRI") compatible medical devices. The Company is a provider of (i) non-magnetic intravenous ("IV") infusion pump system and (ii) a ...